v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating Cash Flow Activities:    
Net loss $ (26,441) $ (35,090)
Reconciliation of net loss to net cash used in operating activities    
Depreciation 151 155
Accretion of debt discount and amortization of financing costs 743 139
Change in fair value of derivative liabilities (7,222) (12,066)
Stock-based compensation expense 1,736 4,490
Payable-in-kind interest on Credit Agreement 5,433 2,493
Operating lease right-of-use assets 160 150
Changes in operating assets and liabilities    
Accounts receivable 114 (741)
Inventory 173 (689)
Prepaid expenses, other current assets and other assets 673 442
Accounts payable, accrued expenses, due to related parties, and other current liabilities 45 664
Accrued interest 0 (657)
Operating lease liabilities (183) (170)
Net cash used in operating activities (24,618) (40,880)
Investing Cash Flow Activities:    
Purchases of equipment and leasehold improvements 0 0
Net cash from investing activities 0 0
Financing Cash Flow Activities:    
Proceeds from issuance of common stock and warrant 14,146 32,219
Offering costs for common stock and warrants issuance (806) (281)
Payment of employee tax obligations related to vesting restricted stock units (1) (8)
Net cash provided by financing activities 13,339 31,930
Net increase in cash, cash equivalents and restricted cash (11,279) (8,950)
Cash, cash equivalents and restricted cash, beginning of the period 29,854 65,221
Cash, cash equivalents and restricted cash, end of the period 18,575 56,271
Supplemental cash flow information:    
Issuance of stock purchase warrants $ 0 $ 224